Original investigations
Pathogenesis and treatment of kidney disease and hypertension
Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease

https://doi.org/10.1053/j.ajkd.2004.11.011Get rights and content

Background: Patients with end-stage renal disease on maintenance dialysis therapy have a high prevalence of cardiovascular risk factors and cardiovascular disease (CVD). A similar finding is noted in patients with chronic kidney disease (CKD). The important contributors are premature and accelerated atherosclerosis and vascular calcification. We assessed the severity of arterial stiffness in 102 patients with CKD by using pulse wave velocity (PWV) and sought to identify associated risk factors. Methods: PWV was measured by calculating the distance traveled by the flow wave and divided by the time delay. Correlations between PWV and traditional cardiovascular risk factors, estimated glomerular filtration rate (GFR) per 1.73 m2, blood pressure (BP), and pulse pressure (PP) were analyzed. Results: PWV values in patients with CKD stages 1 to 2 and the age-matched control group were similar. There was a significant trend for a stepwise increase in PWV corresponding to advance in CKD stage (P < 0.0001). Univariate linear regression analysis showed that age, prior CVD, diabetes, hypertension, any high risk, estimated GFR per 1.73 m2, systolic BP, and PP correlated with PWV. In the multivariate model, decreased estimated GFR per 1.73 m2 and increased systolic BP were independently associated with increased PWV in patients with CKD (model R 2 = 0.539; P < 0.0001). Conclusion: This is the first study to show a greater PWV in patients with more advanced CKD from stages 1 to 5. Estimated GFR per 1.73 m2 and systolic BP were the major clinical determinants of arterial stiffness in patients with CKD independent of conventional risk factors for CVD.

Section snippets

Patients

In this cross-sectional study, 121 patients with CKD who received medical treatment and follow-up from September 2003 to May 2004 at National Cheng Kung University Hospital in Tainan, Taiwan, were evaluated. The diagnosis and classification of CKD were established according to criteria from the Clinical Practice Guidelines for Chronic Kidney Disease from the National Kidney Foundation–Kidney Disease Outcomes Quality Initiative.25 Estimated glomerular filtration rate (GFR) was derived from the

Results

Hypertension, dyslipidemia, the presence of 2 or more traditional cardiovascular risk factors, and any high risk were shown by more than half the total series of patients. Compared with subjects with CKD stages 1 to 2, patients with CKD stages 3 to 4 and stage 5 were older and had a greater prevalence of CVD, DM, and hypertension and higher systolic BP, PP, and PWV. Significant differences were found in age, hypertension, estimated GFR per 1.73 m2, systolic BP, pulse pressure (PP), and PWV

Discussion

Atherosclerosis, a primary intimal disease characterized by the presence of plaques and occlusive lesions, is preceded by endothelial injury and dysfunction and may begin early in life, especially in patients with CKD. Increased arterial stiffness and decreased compliance are the major alterations in conduit function, which can be evaluated noninvasively by measuring the PWV of large arteries.27, 28 Mourad et al24 reported a significant negative association between PWV and creatinine clearance

References (52)

  • R.M. Henry et al.

    Mild renal insufficiency is associated with increased cardiovascular mortalityThe Hoorn Study

    Kidney Int

    (2002)
  • E. Ishimura et al.

    Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus

    Am J Kidney Dis

    (2001)
  • G.M. London et al.

    Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients

    Kidney Int Suppl

    (2003)
  • K. Shinohara et al.

    Arterial stiffness in predialysis patients with uremia

    Kidney Int

    (2004)
  • M. Tozawa et al.

    Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis

    Kidney Int

    (2002)
  • A. Lindner et al.

    Accelerated atherosclerosis in prolonged maintenance hemodialysis

    N Engl J Med

    (1974)
  • A.P. Guérin et al.

    Arterial stiffening and vascular calcifications in end-stage renal disease

    Nephrol Dial Transplant

    (2000)
  • W.G. Goodman et al.

    Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

    N Engl J Med

    (2000)
  • J. Blacher et al.

    Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease

    Hypertension

    (2001)
  • G.M. London et al.

    Arterial media calcification in end-stage renal diseaseImpact on all-cause and cardiovascular mortality

    Nephrol Dial Transplant

    (2003)
  • J. Blacher et al.

    Impact of aortic stiffness on survival in end-stage renal disease

    Circulation

    (1999)
  • T. Shoji et al.

    Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease

    J Am Soc Nephrol

    (2001)
  • J. Blacher et al.

    Prognostic significance of arterial stiffness measurements in end-stage renal disease patients

    Curr Opin Nephrol Hypertens

    (2002)
  • P. Muntner et al.

    Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States

    J Am Soc Nephrol

    (2002)
  • J.F. Mann et al.

    Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramiprilThe HOPE randomized trial

    Ann Intern Med

    (2001)
  • L.M. Ruilope et al.

    Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study

    J Am Soc Nephrol

    (2001)
  • Cited by (295)

    • Arterial stiffness and pulsatile hemodynamics in renal disease

      2022, Textbook of Arterial Stiffness and Pulsatile Hemodynamics in Health and Disease
    • Association of Arterial Stiffness With Chronic Kidney Disease Progression and Mortality

      2021, Heart Lung and Circulation
      Citation Excerpt :

      Accordingly, it has been hypothesised that moderately decreased renal function may be the cause of increased AS. It was also suggested that central AS may be an important pathophysiologic phenotype of vascular disease in CKD [24–27]. Several other mechanisms might be involved, including endothelial dysfunction, activation of the renin-angiotensin system (RAS), and qualitative and quantitative changes in the arterial wall such as glycation end-products, lipid peroxidation, elastin fragmentation, vascular smooth muscle cell hyperplasia, increased collagen, and decreased number of elastic fibres.

    View all citing articles on Scopus

    Originally published online as doi:10.1053/j.ajkd.2004.11.011 on January 14, 2005.

    Supported in part by grant no. NSC92-2314-B-006-064 from the National Science Council, Taipei, Taiwan.

    View full text